Five-Year Breast Cancer Relative Survival Rates
Michigan Residents,1995-2005

Table 71-A
All Races, Female
Year of
Diagnosis 		All Stages Localized Regional Distant Unknown
Michigan SEER Michigan SEER Michigan SEER Michigan SEER Michigan SEER
2005 88.3 ±0.6 89.0 ±0.2 97.8 ±0.7 98.2 ±0.2 83.2 ±1.2 85.5 ±0.4 19.1 ±2.8 29.5 ±1.0 68.6 ±3.8 46.4 ±2.6
2004 86.9 ±0.6 88.8 ±0.2 97.3 ±0.6 98.5 ±0.2 82.9 ±1.1 85.2 ±0.4 21.9 ±2.7 28.1 ±0.9 53.8 ±3.1 49.3 ±2.1
2003 87.4 ±0.6 88.8 ±0.2 97.8 ±0.6 98.3 ±0.2 82.9 ±1.1 85.0 ±0.4 23.0 ±3.0 27.8 ±0.9 50.6 ±2.9 51.5 ±2.0
2002 89.2 ±0.6 89.1 ±0.2 99.3 ±0.6 98.7 ±0.2 83.0 ±1.1 84.5 ±0.4 25.1 ±2.9 28.4 ±0.9 58.5 ±3.3 57.3 ±1.9
2001 88.2 ±0.6 89.1 ±0.2 97.9 ±0.6 98.4 ±0.2 80.7 ±1.2 84.6 ±0.4 23.6 ±2.7 28.0 ±0.9 77.5 ±2.6 63.0 ±1.9
2000 88.9 ±0.6 88.7 ±0.2 97.8 ±0.6 98.2 ±0.2 81.1 ±1.1 84.2 ±0.4 29.1 ±3.1 27.5 ±0.9 74.1 ±2.9 64.3 ±1.7
1999 88.2 ±0.6 89.7 ±0.3 98.1 ±0.6 98.9 ±0.3 80.9 ±1.2 84.8 ±0.6 18.9 ±2.7 24.9 ±1.3 69.0 ±2.9 57.4 ±3.0
1998 86.9 ±0.6 89.1 ±0.3 96.9 ±0.6 98.6 ±0.3 80.6 ±1.2 82.8 ±0.6 23.0 ±2.7 28.1 ±1.4 68.1 ±2.7 59.2 ±2.8
1997 85.8 ±0.6 88.3 ±0.3 96.8 ±0.6 98.1 ±0.3 76.9 ±1.3 82.1 ±0.6 15.5 ±2.4 24.9 ±1.3 67.6 ±2.6 63.5 ±2.4
1996 84.9 ±0.6 87.1 ±0.3 96.2 ±0.7 97.5 ±0.3 77.8 ±1.3 80.2 ±0.6 18.9 ±2.5 23.8 ±1.3 60.1 ±2.8 56.3 ±2.5
1995 85.2 ±0.6 86.7 ±0.3 96.1 ±0.7 97.5 ±0.3 77.5 ±1.3 78.4 ±0.7 18.9 ±2.6 23.2 ±1.4 68.8 ±2.4 62.7 ±2.5
                     

Table 71-B
White Female
Year of
Diagnosis 		All Stages Localized Regional Distant Unknown
Michigan SEER Michigan SEER Michigan SEER Michigan SEER Michigan SEER
2005 89.8 ±0.7 90.3 ±0.3 98.5 ±0.7 99.1 ±0.3 85.1 ±1.3 86.7 ±0.5 21.2 ±3.3 31.2 ±1.2 68.3 ±4.0 44.3 ±3.0
2004 88.2 ±0.6 90.2 ±0.2 97.8 ±0.7 99.1 ±0.2 84.0 ±1.2 86.6 ±0.4 22.2 ±3.1 29.9 ±1.1 55.9 ±3.4 49.4 ±2.4
2003 89.0 ±0.6 90.2 ±0.2 98.6 ±0.6 99.1 ±0.2 84.8 ±1.2 86.4 ±0.4 20.9 ±3.4 29.3 ±1.1 50.5 ±3.2 51.1 ±2.3
2002 90.8 ±0.6 90.5 ±0.2 99.8 ±0.6 99.5 ±0.2 85.3 ±1.2 85.9 ±0.4 26.5 ±3.4 30.9 ±1.1 58.5 ±3.5 58.5 ±2.2
2001 89.3 ±0.6 90.4 ±0.2 98.2 ±0.6 99.0 ±0.2 82.1 ±1.2 86.1 ±0.4 22.6 ±3.0 29.8 ±1.1 78.0 ±2.8 63.4 ±2.1
2000 90.2 ±0.6 89.7 ±0.2 98.5 ±0.6 98.7 ±0.2 82.8 ±1.2 85.3 ±0.4 29.4 ±3.5 28.6 ±1.0 73.9 ±3.2 65.5 ±1.9
1999 89.2 ±0.6 90.7 ±0.3 98.5 ±0.6 99.4 ±0.3 82.0 ±1.3 85.8 ±0.6 19.3 ±3.0 26.7 ±1.5 69.0 ±3.1 59.4 ±3.4
1998 88.1 ±0.6 90.3 ±0.3 97.2 ±0.7 99.3 ±0.3 81.8 ±1.3 84.1 ±0.6 24.1 ±3.0 30.2 ±1.6 71.0 ±2.9 59.1 ±3.3
1997 87.7 ±0.6 89.4 ±0.3 97.6 ±0.7 98.7 ±0.4 79.3 ±1.4 83.9 ±0.7 15.9 ±2.7 26.2 ±1.5 70.9 ±2.9 62.9 ±2.8
1996 85.7 ±0.7 88.3 ±0.4 96.8 ±0.7 97.9 ±0.4 78.0 ±1.4 82.1 ±0.7 19.4 ±2.8 25.0 ±1.5 60.8 ±2.9 54.7 ±2.9
1995 86.6 ±0.7 87.9 ±0.4 96.8 ±0.7 98.1 ±0.4 79.8 ±1.3 80.1 ±0.7 18.9 ±2.8 24.5 ±1.5 70.9 ±2.6 62.4 ±2.9
                     

Table 71-C
Black Female
Year of
Diagnosis 		All Stages Localized Regional Distant Unknown
Michigan SEER Michigan SEER Michigan SEER Michigan SEER Michigan SEER
2005 75.2 ±2.2 77.3 ±0.8 90.3 ±2.6 92.4 ±1.0 69.1 ±3.9 74.2 ±1.5 13.2 ±5.0 19.5 ±2.1 69.4 ±12.3 42.7 ±6.8
2004 75.6 ±2.0 77.8 ±0.7 92.5 ±2.2 93.2 ±0.8 72.3 ±3.5 75.4 ±1.2 21.8 ±5.6 18.3 ±1.9 29.5 ±7.0 38.1 ±5.7
2003 73.4 ±2.0 76.6 ±0.8 88.6 ±2.5 91.9 ±0.9 69.2 ±3.3 74.4 ±1.2 27.3 ±6.6 19.0 ±2.0 42.5 ±7.9 46.4 ±5.3
2002 75.3 ±2.0 76.7 ±0.8 93.9 ±2.3 92.2 ±0.9 66.4 ±3.3 73.5 ±1.3 21.7 ±5.6 15.4 ±1.9 42.3 ±11.6 41.1 ±5.1
2001 78.8 ±2.0 76.9 ±0.8 93.8 ±2.2 93.3 ±0.9 70.4 ±3.4 72.0 ±1.3 25.7 ±6.5 20.0 ±2.1 62.6 ±10.4 55.8 ±5.6
2000 77.7 ±1.9 78.6 ±0.8 91.6 ±2.3 94.3 ±0.9 70.1 ±3.4 75.1 ±1.2 26.9 ±6.5 19.4 ±2.1 69.2 ±8.4 50.4 ±5.1
1999 80.0 ±1.9 79.9 ±1.1 93.9 ±2.2 95.4 ±1.2 74.2 ±3.2 75.4 ±1.9 11.4 ±5.4 16.8 ±3.1 59.9 ±9.8 38.1 ±8.9
1998 77.3 ±2.0 77.6 ±1.2 93.4 ±2.3 92.9 ±1.3 72.8 ±3.2 70.8 ±2.1 18.6 ±6.4 17.9 ±3.3 38.9 ±7.8 50.7 ±6.9
1997 70.9 ±2.0 75.6 ±1.2 89.3 ±2.4 92.3 ±1.4 63.1 ±3.5 67.8 ±2.2 12.4 ±5.3 11.9 ±2.8 35.2 ±7.1 59.4 ±6.7
1996 77.6 ±2.1 75.6 ±1.2 90.8 ±2.4 91.8 ±1.4 74.9 ±3.7 69.1 ±2.2 17.0 ±5.5 16.6 ±3.1 43.4 ±9.8 58.0 ±7.0
1995 72.9 ±2.1 74.3 ±1.3 90.0 ±2.4 92.2 ±1.4 62.2 ±3.8 61.6 ±2.3 14.9 ±6.2 12.4 ±3.1 45.8 ±6.9 48.1 ±6.6
                     



Notes:

Relative survival:Cancer survival in the absence of other causes of death is calculated using survival life tables. Relative survival is defined as the ratio of the proportion of observed survivors (all causes of death) in a cohort of cancer patients to the proportion of expected survivors in a comparable cohort of cancer-free individuals. The formulation is based on the assumption of independent competing causes of death. Since a cohort of cancer-free individuals is difficult to obtain, we use expected life tables and assume that the cancer deaths are a negligible proportion of all deaths.


Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel.

Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes.

Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes.


Source of Michigan Data: Michigan Department of Health and Human Services, Vital Records and Health Data Development Section. Survival data from the Michigan Cancer Surveillance Program are developed through passive surveillance of mortality by matching the registry with state and national mortality files.
Source of SEER Data: National Cancer Institute, Bethesda, MD
Last Updated:: December 13, 2012